No Data
No Data
Zhejiang Zhenyuan (000705.SZ): The subsidiary Zhenyuan Biotech is building a production line for histidine and other products, which is expected to be tested by the end of this year
Gelonghui, May 7 | Zhejiang Zhenyuan (000705.SZ) said on the investor interactive platform that the company's subsidiary Zhenyuan Biotech is building production lines for histidine, levodopa, tyrosine and other products, which are expected to be put into trial production by the end of this year and officially put into production in 2025.
Zhejiang Zhenyuan (000705.SZ): Net profit of 19.245.99 million yuan in the first quarter increased 3.67% year-on-year
Gelonghui, April 29丨Zhejiang Zhenyuan (000705.SZ) released its report for the first quarter of 2024. Operating income for the reporting period was 1,045 billion yuan, down 4.87% year on year; net profit attributable to shareholders of listed companies was 19.245.99 million yuan, up 3.67% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 18.5337 million yuan, up 2.16% year on year; basic earnings per share were 0.0576 yuan
Zhejiang Zhenyuan (000705.SZ): Proposed capital increase of no more than 495 million yuan
Gelonghui, April 29丨Zhejiang Zhenyuan (000705.SZ) announced that the company plans to issue shares to specific targets to raise a total of no more than 495 million yuan. It is used for Zhejiang Zhenyuan Biotechnology Co., Ltd.'s biotargeted synthesis of 2,400 tons of histidine, 1,000 tons of levodopa, 1,000 tons of tyrosine and other series of products in the Shangyu Industrialization Base Construction Project and Zhejiang Zhenyuan Pharmaceutical Co., Ltd.'s API agglomeration upgrade project.
Zhejiang Zhenyuan (000705.SZ): Net profit for 2023 increased 4.79% to 81.6426 million yuan, plan to pay 10.0.6 yuan
Gelonghui, March 21丨Zhejiang Zhenyuan (000705.SZ) announced its 2023 annual report. In 2023, the company achieved operating income of 4.106 billion yuan, a year-on-year decrease of 0.94%; net profit attributable to shareholders of listed companies was 81.6426 million yuan, up 4.79% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 782,125 million yuan, an increase of 14.40% year on year; basic earnings per share of 0.24 yuan; it is intended to distribute a cash dividend of 0.60 yuan (tax included) to all shareholders for every 10 shares.
Zhejiang Zhenyuan (000705.SZ): No in-depth business cooperation with Wahaha Group
Gelonghui March 15 丨 Some investors asked Zhejiang Zhenyuan (000705.SZ) on the investor interactive platform, “Has your company developed in-depth business cooperation with Zhejiang Wahaha Group?” The company replied that the company and Wahaha Group have not developed further business cooperation.
Zhejiang Zhenyuan (000705.SZ): Holds 0.11% of Zhejiang Wahaha Industrial Co., Ltd.
Gelonghui March 8 丨 Zhejiang Zhenyuan (000705.SZ) said on the investor interactive platform that the company holds 0.11% of Zhejiang Wahaha Industrial Co., Ltd. The company is unaware of Wahaha Group's acquisition or listing plans.
No Data